20th Mar 2018 15:06
20 March 2018
CVS Group plc
("CVS" or the "Company")
Exercise of Options, Director/PDMR and PCA Dealing and Total Voting Rights
CVS, the UK's leading provider of veterinary services, announces that on 16 March 2018 Simon Innes, Chief Executive Officer, together with certain other employees of the Company exercised options at 296 pence per share over an aggregate of 8,269 ordinary shares of 0.2 pence each in the Company (the "SAYE Shares") ("Ordinary Shares") in connection with the Company's December 2014 - December 2017 (January 2018 Maturity) Save As You Earn Scheme.
Simon Innes, exercised options over 6,081 Ordinary Shares, subsequent to which on 20 March 2018, the Company was notified that on 16 March 2018, Simon Innes sold 3,040 Ordinary Shares at a price of 1,065 pence per Ordinary Share. Also on 16 March 2018 Mr Innes transferred, conditional upon the issue of the SAYE Shares, 3,041 Ordinary Shares to his wife, Shirley Innes, a Person Closely Associated ("PCA") of Mr Innes.
As a result, Mr Innes' total interest in the Company, including his wife's holding, has increased to 255,266 Ordinary Shares, representing 0.36 per cent of the total voting rights of the Company.
In addition, the Company announces that on 20 March 2018 Mike McCollum, Non-Executive Director of the Company, sold 38,677 Ordinary Shares at a price of 1,020 pence per Ordinary Share. As a result Mr McCollum holds 38,678 Ordinary Shares, representing less 0.06 per cent of the total voting rights of the Company.
The SAYE Shares rank pari passu with all existing Ordinary Shares. The issue of the SAYE Shares took place on 19 March 2018 and has been satisfied via the Company's block listing which was announced on 19 December 2017.
Following issue of the SAYE Shares, the Company's total issued share capital will consist of 70,308,726 Ordinary Shares with one voting right per share. The Company does not hold any Ordinary Shares in Treasury. Therefore, following the issue of the SAYE Shares, the total number of voting rights in the Company is 70,308,726. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.
The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.
Contacts: CVS Group plc Simon Innes, Chief Executive Nick Perrin, Finance Director
|
Tel: 01379 644 288 |
N+1 Singer (Nominated Adviser & Broker) Aubrey Powell Liz Yong James Hopton | Tel: 020 7496 3000 |
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Simon Innes | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Chief Executive | ||||
b)
| Initial notification /Amendment
| Initial Notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| CVS Group plc | ||||
b)
| LEI
| 213800J41XDQ2NX48O05 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary Shares of 0.2 pence each
GB00B2863827
| ||||
b)
| Nature of the transaction
|
i. Option Exercise ii. Sale of Ordinary Shares by a PDMR iii. Transfer of Ordinary Shares by a PDMR to a PCA | ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
|
n/a | ||||
e)
| Date of the transaction
|
i. 16 March 2018 ii. 16 March 2018 iii. 16 March 2018 | ||||
f)
| Place of the transaction
|
i. Outside of trading venue ii. London Stock Exchange (XLON) iii. Outside of trading venue | ||||
1 | Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Shirley Innes | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| PCA of Simon Innes | ||||
b)
| Initial notification /Amendment
| Initial Notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| CVS Group plc | ||||
b)
| LEI
| 213800J41XDQ2NX48O05 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary Shares of 0.2 pence each
GB00B2863827
| ||||
b)
| Nature of the transaction
|
Receipt of transfer to Ordinary Shares by a PDMR to a PCA | ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
|
n/a | ||||
e)
| Date of the transaction
| 16 March 2018 | ||||
f)
| Place of the transaction
| Outside of trading venue | ||||
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Mike McCollum | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Non-executive director | ||||
b)
| Initial notification /Amendment
| Initial Notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| CVS Group plc | ||||
b)
| LEI
| 213800J41XDQ2NX48O05 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary Shares of 0.2 pence each
GB00B2863827
| ||||
b)
| Nature of the transaction
| Sale of Ordinary Shares | ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
|
n/a | ||||
e)
| Date of the transaction
| 20 March 2018 | ||||
f)
| Place of the transaction
| London Stock Exchange (XLON) | ||||
Related Shares:
CVS Group